<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>煜森资本 | wechat-feeds</title><link>http://MzI3MzcxODkyNQ.favicon.privacyhide.com/favicon.ico</link><description>医疗健康投融资平台  科学家创业平台</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 03 Jun 2021 14:53:19 +0800</pubDate><image><url>http://MzI3MzcxODkyNQ.favicon.privacyhide.com/favicon.ico</url><title>煜森资本 | wechat-feeds</title><link>http://MzI3MzcxODkyNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>6月，去成都的街头走一走</title><link>https://mp.weixin.qq.com/s/6Blls4CDVlcrH3jAEFLkvA</link><description></description><content:encoded><![CDATA[6月，去成都的街头走一走]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>聚焦：2021基因治疗领域面临的5大问题</title><link>https://mp.weixin.qq.com/s/CCz7x3LP8GA8ki4hVwH88A</link><description></description><content:encoded><![CDATA[聚焦：2021基因治疗领域面临的5大问题]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>有临医药完成逾亿元A+轮融资，钟鼎资本领投，千骥资本持续加码</title><link>https://mp.weixin.qq.com/s/mp9OPebPVeDYjUv6vev2gw</link><description></description><content:encoded><![CDATA[有临医药完成逾亿元A+轮融资，钟鼎资本领投，千骥资本持续加码]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>斯微生物宣布完成12亿元新一轮融资</title><link>https://mp.weixin.qq.com/s/V32bww3-S6YSqU6X1LX4fQ</link><description></description><content:encoded><![CDATA[斯微生物宣布完成12亿元新一轮融资]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>入局mRNA领域，艾美疫苗控股丽凡达生物</title><link>https://mp.weixin.qq.com/s/KbM6agsRTx3d-EobX8cWyg</link><description></description><content:encoded><![CDATA[入局mRNA领域，艾美疫苗控股丽凡达生物]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>科兴新冠疫苗进WHO紧急使用清单 | 上海盟科抗菌新药获批上市...</title><link>https://mp.weixin.qq.com/s/30Cybq0mMIJL_1R9KbnWOA</link><description></description><content:encoded><![CDATA[科兴新冠疫苗进WHO紧急使用清单 | 上海盟科抗菌新药获批上市...]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>联拓生物1.47亿美元引进一款慢性鼻窦炎药物大中华区权益</title><link>https://mp.weixin.qq.com/s/K_Bei4LLdkKlni8vsr6eCg</link><description></description><content:encoded><![CDATA[联拓生物1.47亿美元引进一款慢性鼻窦炎药物大中华区权益]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>靶向PD-L1/TGF-β，博际生物双功能性融合蛋白获FDA临床批准</title><link>https://mp.weixin.qq.com/s/-MRmlNudJ5hk6JsgvWiu7Q</link><description></description><content:encoded><![CDATA[靶向PD-L1/TGF-β，博际生物双功能性融合蛋白获FDA临床批准]]></content:encoded><pubDate>Thu, 03 Jun 2021 11:34:14 +0800</pubDate></item><item><title>这些国内小众旅游地太美了~</title><link>https://mp.weixin.qq.com/s/dFjQuO8tYyMDp39DQIjW_A</link><description></description><content:encoded><![CDATA[这些国内小众旅游地太美了~]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>中科院科学家创立，博骥源医药完成pre-A轮融资</title><link>https://mp.weixin.qq.com/s/ep3Xf9CQCdvyexepYVD0nA</link><description></description><content:encoded><![CDATA[中科院科学家创立，博骥源医药完成pre-A轮融资]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>百济神州泽布替尼全球3期头对头临床试验最新数据公布</title><link>https://mp.weixin.qq.com/s/jPAkk84jRWRXH3EXB4qlXg</link><description></description><content:encoded><![CDATA[百济神州泽布替尼全球3期头对头临床试验最新数据公布]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>美诺华与默沙东举行战略合作签约仪式</title><link>https://mp.weixin.qq.com/s/_p1seLAjHkBm7vhqqDPBSA</link><description></description><content:encoded><![CDATA[美诺华与默沙东举行战略合作签约仪式]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>泽布替尼 vs 伊布替尼治疗复发难治CLL/SLL头对头III期数据显示优效</title><link>https://mp.weixin.qq.com/s/p3rM5yJVReWmug7aV5FzHQ</link><description></description><content:encoded><![CDATA[泽布替尼 vs 伊布替尼治疗复发难治CLL/SLL头对头III期数据显示优效]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>万春原创新药普那布林获FDA优先审评 | 诺华VEGF品种终止Ⅲ期MERLIN研究...</title><link>https://mp.weixin.qq.com/s/xZvpxzOQM0jpVJffay6H7w</link><description></description><content:encoded><![CDATA[万春原创新药普那布林获FDA优先审评 | 诺华VEGF品种终止Ⅲ期MERLIN研究...]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>CAR-T细胞疗法最新研究进展</title><link>https://mp.weixin.qq.com/s/bQn2XkW9CnGGiFG55PTZfA</link><description></description><content:encoded><![CDATA[CAR-T细胞疗法最新研究进展]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>基石药业：有望上演中国版K药逆袭</title><link>https://mp.weixin.qq.com/s/5tFmnJIuVIvQm-nDE0Fnhw</link><description></description><content:encoded><![CDATA[基石药业：有望上演中国版K药逆袭]]></content:encoded><pubDate>Wed, 02 Jun 2021 11:30:24 +0800</pubDate></item><item><title>6·1| 愿你出走半生，依然童心不泯</title><link>https://mp.weixin.qq.com/s/aiNN_MTHER-xdo3dAfySbg</link><description></description><content:encoded><![CDATA[6·1| 愿你出走半生，依然童心不泯]]></content:encoded><pubDate>Tue, 01 Jun 2021 11:43:12 +0800</pubDate></item><item><title>创响生物完成1亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/sW7jjKY2qPJOhVUK9p2nNg</link><description></description><content:encoded><![CDATA[创响生物完成1亿美元C轮融资]]></content:encoded><pubDate>Tue, 01 Jun 2021 11:43:12 +0800</pubDate></item><item><title>医疗大健康投融资周报</title><link>https://mp.weixin.qq.com/s/8lCwfx6IHqhB4BGS2QExeg</link><description></description><content:encoded><![CDATA[医疗大健康投融资周报]]></content:encoded><pubDate>Tue, 01 Jun 2021 11:43:12 +0800</pubDate></item><item><title>A轮融资亿元！博斯腾科技认知症数字疗法解决方案，助力开启认知革命</title><link>https://mp.weixin.qq.com/s/jEBqXu8fDjKdylWTL2JI3g</link><description></description><content:encoded><![CDATA[A轮融资亿元！博斯腾科技认知症数字疗法解决方案，助力开启认知革命]]></content:encoded><pubDate>Tue, 01 Jun 2021 11:43:12 +0800</pubDate></item></channel></rss>